STAT3 and hepatocellular carcinoma: Several cancer cell lines examined in this study, including human hepatocellular carcinoma, lung cancer, breast and canine mammary cancer, human and canine osteosarcoma, human melanoma and pancreatic cancer showed a consistent and quick cell death response when a HIF-1α was combined to CT and a selective STAT3 inhibitor.